PDS Biotechnology Corporation

NASDAQ: PDSB · Healthcare · Biotechnology

PublicHQ Princeton, NJ · MercerCIK 0001472091Reports USD

#1 of 1,394 Healthcare companies by revenue

EA Score

——

FH 23DQ —GM —SS 49

v0.1 · 35/100 weight · pillars only

↑ market scale, listing tenure · ↓ Piotroski F, return on equity

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$34.5M

Employees

Market cap

$47.6M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Net income-$34.5M-$34.5M2025

Operating income-$31.5M-$31.5M2025

Total assets$30.5M$30.5M2025

Liabilities$21.2M$21.2M2025

Equity$9.3M$9.3M2025

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

PDS Biotechnology Corporation earned -$34.5M in FY2025 net income.

Peers · Healthcare

Metagenomi, Inc. Common Stock39D Horizon Space Acquisition II Corp.——Vicapsys Life Sciences, Inc.——Decibel Cannabis Company Inc.62C

Neighbors

Mercer →

Bristol-Myers Squibb Company$48.2B85A Essential Properties Realty Trust, Inc.$561.2M69B Clearway Energy, Inc.$1.4B56C Miami International Holdings, Inc. $1.4B43D Kardigan, Inc.——UroGen Pharma Ltd.$109.8M54D

Key facts

CEOFrank K. Bedu-Addo

SectorHealthcare

IndustryBiotechnology

HeadquartersPrinceton, NJ

ExchangeNASDAQ: PDSB

Employees24

IPO date2015-09-30

Latest filings

DEF 14A2026-06-26 8-K2026-06-15 8-K2026-06-15 8-K2026-06-02 10-Q2026-05-14 8-K2026-05-13 8-K2026-05-01 8-K2026-04-24

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.